Prevalence and Antimicrobial Resistance of Vibrio parahaemolyticus Isolated from Raw Shellfish in Poland

2015 ◽  
Vol 78 (5) ◽  
pp. 1029-1033 ◽  
Author(s):  
MAGDALENA LOPATEK ◽  
KINGA WIECZOREK ◽  
JACEK OSEK
Keyword(s):  
Antimicrobial Resistance ◽  
Vibrio Parahaemolyticus ◽  
Marine Bacterium ◽  
Dilution Method ◽  
Bacterial Isolates ◽  
Bivalve Molluscs ◽  
First Line ◽  
Toxr Gene ◽  
Species Specific ◽  
Microbroth Dilution

Vibrio parahaemolyticus is a marine bacterium recognized as an important cause of gastroenteritis in humans consuming contaminated shellfish. In recent years, increasing resistance to ampicillin and aminoglycosides has been observed among V. parahaemolyticus isolates. However, the first-line antimicrobials such as tetracyclines and fluoroquinolones remained highly effective against these bacteria. The aim of this study was to evaluate the occurrence of V. parahaemolyticus in live bivalve molluscs available on the Polish market and to determine the antimicrobial resistance of the recovered isolates. A total of 400 shellfish samples (mussels, oysters, clams, and scallops) from 2009 to 2012 were tested using the International Organization for Standardization standard 21872-1 method and PCR for the species-specific toxR gene. Antimicrobial susceptibility of the isolates was determined using a microbroth dilution method. V. parahaemolyticus was identified in 70 (17.5%) of the 400 samples, and the toxR gene was confirmed in 64 (91.4%) of these isolates. Most of the isolates were recovered from clams (31 isolates; 48.4% prevalence) followed by mussels (17 isolates; 26.6% prevalence). More V. parahaemolyticus–positive samples were found between May and September (22.7% prevalence) than between October and April (11.4% prevalence). Antibiotic profiling revealed that most isolates were resistant to ampicillin (56 isolates; 87.5%) and to streptomycin (45 isolates; 70.3%), but all of them were susceptible to tetracycline and chloramphenicol. Forty-one isolates (64.1%) were resistant to two or more antimicrobials; however, only one isolate (1.6%) was resistant to three antimicrobial classes. The antimicrobials used in treatment of human V. parahaemolyticus infection had high efficacy against the bacterial isolates tested. This study is the first concerning antibiotic resistance of V. parahaemolyticus isolates in Poland, and the results obtained indicate that these bacteria may pose a health risk to consumers.

Antibiotic Resistance of Salmonella Isolated from Hog, Beef, and Chicken Carcass Samples from Provincially Inspected Abattoirs in Ontario

2004 ◽  
Vol 67 (3) ◽  
pp. 448-455 ◽  
Author(s):  
C. LARKIN ◽  
C. POPPE ◽  
B. MCNAB ◽  
B. MCEWEN ◽  
A. MAHDI ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
The United States ◽  
Test Methods ◽  
Dilution Method ◽  
Agar Dilution Method ◽  
Chicken Carcass ◽  
Resistance Patterns ◽  
Agar Dilution ◽  
Microbroth Dilution ◽  
Good Agreement

The emergence of antimicrobial-resistant Salmonella organisms, especially Salmonella Typhimurium DT104, has been reported in many countries, including the United States and Canada. The purposes of this study were to determine the antimicrobial resistance patterns of Salmonella isolated from hog, beef, and chicken carcasses from provincially inspected abattoirs in Ontario and to determine the agreement between the agar dilution method and the microbroth dilution method for measurement of antimicrobial resistance of the isolates. Antimicrobial resistance of Salmonella isolates from hogs (n = 71), beef (n = 24), and chicken (n = 295) to amikacin, ampicillin, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, streptomycin, sulfamethoxazole,and tetracycline was determined using the two methods. None of the 390 isolates were resistant to ciprofloxacin at levels of 0.125 μg/ml. All chicken and hog isolates were sensitive to amikacin, whereas all beef isolates were sensitive to both amikacin and gentamicin. Multiple antimicrobial resistance (resistance to more than one antimicrobial) was found in 29% of bovine isolates and 42% of porcine isolates using both methods for testing and in 42% by the agar dilution and 33% by the microbroth dilution methods in the chicken isolates. Overall, there was good agreement between the two test methods for resistance to most of the antimicrobials, with disagreement found in the results in 1.3% of the isolates for ampicillin and sulfamethoxazole, 8.2% for streptomycin, 5.6% for cephalothin, and 1.0% of the isolates for tetracycline. The lack of agreement between the two test methods was found mostly among the chicken isolates.

scholarly journals The Russian gonococcal antimicrobial susceptibility programme (RU-GASP) – national resistance prevalence in 2007 and 2008, and trends during 2005-2008

2010 ◽  
Vol 15 (14) ◽  
Author(s):  
A Kubanova ◽  
N Frigo ◽  
A Kubanov ◽  
S Sidorenko ◽  
I Lesnaya ◽  
...  
Keyword(s):  
Public Health ◽  
European Union ◽  
Antimicrobial Resistance ◽  
Antimicrobial Susceptibility ◽  
Dilution Method ◽  
Agar Dilution Method ◽  
The European Union ◽  
Beta Lactam ◽  
First Line ◽  
Agar Dilution

Antimicrobial resistance (AMR) in Neisseria gonorrhoeae is a major problem worldwide. In the former Soviet countries including Russia, the knowledge regarding AMR has been highly limited. However, in 2004 the Russian gonococcal antimicrobial susceptibility programme (RU-GASP) was initiated. The aims of this study were to examine and describe the prevalence of N. gonorrhoeae AMR in 2007 and 2008 in Russia, and reveal trends in the period from 2005 to 2008. Gonococcal isolates (660 in 2007 and 900 in 2008) from 36 surveillance sites were examined using agar dilution method. From 2005 to 2008, the proportion of isolates resistant to spectinomycin increased from 0% to 7.2%, and remained high for those resistant to ciprofloxacin (approximately 49%). The resistance to azithromycin was 2.3% and 0.4% in 2007 and 2008, respectively. All isolates between 2005 and 2008 were susceptible to ceftriaxone. In conclusion, the AMR of N. gonorrhoeae in Russia is high, as in most countries in the European Union, and ceftriaxone should be the first line for treatment. If there is no access to ceftriaxone or in the presence of severe beta-lactam antimicrobial allergy, spectinomycin should be used; however, the resistance to spectinomycin has increased. Regular, quality-assured national and international surveillance of AMR in N. gonorrhoeae is crucial globally for public health.

Characteristics and antimicrobial resistance of Campylobacter isolated from pig and cattle carcasses in Poland

2013 ◽  
Vol 16 (3) ◽  
pp. 501-508 ◽  
Author(s):  
K. Wieczorek ◽  
J. Osek
Keyword(s):  
Antimicrobial Resistance ◽  
Virulence Genes ◽  
Inhibitory Concentration ◽  
Dilution Method ◽  
Gene Marker ◽  
Cytolethal Distending Toxin ◽  
Resistance Patterns ◽  
Pig Carcasses ◽  
Microbroth Dilution ◽  
Pathogenic Gene

Abstract A total of 70 Campylobacter isolates recovered from 114 cattle and 177 pig carcasses at the slaughterhouse level were characterized by the presence of 7 putative virulence genes and antimicrobial susceptibility using the microbroth dilution method and minimal inhibitory concentration (MIC). The prevalence of Campylobacter was 14.9% and 29.9% in cattle and pig samples, respectively. The majority of cattle carcasses were contaminated with C. jejuni (64.7%), whereas pig carcasses were mainly positive for C. coli (77.4%). Most of the strain, irrespective of origin, possessed at least one pathogenic gene marker tested, mainly flaA and cadF genes responsible for motility and adherence to host epithelial cells, respectively. Several isolates also possessed the cdtA and cdtB genes responsible for the production of cytolethal distending toxin. Antibiotic profiling showed that campylobacters were most frequently resistant to quinolones (nalidixic acid and ciprofloxacin, total 57.1% of isolates) followed by streptomycin (52.9%, only C. coli strains) and tetracycline (51.4%). Resistance to erythromycin was demonstrated only in 4 C. coli strains of pig origin. None of the isolates, irrespective of origin, was resistant to gentamycin. Multi-resistance patterns, defined as resistance to antimicrobials of at least two different classes, were observed among 65.4% of the isolates, mainly C. coli recovered from pig carcasses.

scholarly journals The Impact of an Efflux Pump Inhibitor on the Activity of Free and Liposomal Antibiotics against Pseudomonas aeruginosa

Pharmaceutics ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 577
Author(s):  
Douweh Leyla Gbian ◽  
Abdelwahab Omri
Keyword(s):  
Cystic Fibrosis ◽  
Pseudomonas Aeruginosa ◽  
Efflux Pump ◽  
Antimicrobial Activities ◽  
Dilution Method ◽  
Efflux Pump Inhibitor ◽  
Signal Production ◽  
Lung Infections ◽  
The Impact ◽  
Microbroth Dilution

The eradication of Pseudomonas aeruginosa in cystic fibrosis patients has become continuously difficult due to its increased resistance to treatments. This study assessed the efficacy of free and liposomal gentamicin and erythromycin, combined with Phenylalanine arginine beta-naphthylamide (PABN), a broad-spectrum efflux pump inhibitor, against P. aeruginosa isolates. Liposomes were prepared and characterized for their sizes and encapsulation efficiencies. The antimicrobial activities of formulations were determined by the microbroth dilution method. Their activity on P. aeruginosa biofilms was assessed, and the effect of sub-inhibitory concentrations on bacterial virulence factors, quorum sensing (QS) signals and bacterial motility was also evaluated. The average diameters of liposomes were 562.67 ± 33.74 nm for gentamicin and 3086.35 ± 553.95 nm for erythromycin, with encapsulation efficiencies of 13.89 ± 1.54% and 51.58 ± 2.84%, respectively. Liposomes and PABN combinations potentiated antibiotics by reducing minimum inhibitory and bactericidal concentrations by 4–32 fold overall. The formulations significantly inhibited biofilm formation and differentially attenuated virulence factor production as well as motility. Unexpectedly, QS signal production was not affected by treatments. Taken together, the results indicate that PABN shows potential as an adjuvant of liposomal macrolides and aminoglycosides in the management of lung infections in cystic fibrosis patients.

Antimicrobial resistance in bacterial isolates from companion animals in Buenos Aires, Argentina: 2011–2017 retrospective study

2021 ◽  
Author(s):  
María Valeria Rumi ◽  
Ezequiel Nuske ◽  
Javier Mas ◽  
Andrea Argüello ◽  
Gabriel Gutkind ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Antimicrobial Resistance ◽  
Buenos Aires ◽  
Companion Animals ◽  
Bacterial Isolates

scholarly journals Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009–2019

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Aliaksandra Aniskevich ◽  
Iryna Shimanskaya ◽  
Iryna Boiko ◽  
Tatyana Golubovskaya ◽  
Daniel Golparian ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Neisseria Gonorrhoeae ◽  
Eastern Europe ◽  
Treatment Guidelines ◽  
Statistical Significance ◽  
Antimicrobial Treatment ◽  
National Guidelines ◽  
First Line ◽  
Exact Test ◽  
The Republic

Abstract Background Limited antimicrobial resistance (AMR) data for Neisseria gonorrhoeae are available in Eastern Europe. We investigated AMR in N. gonorrhoeae isolates in the Republic of Belarus from 2009 to 2019, antimicrobial treatment recommended nationally, and treatment given to patients with gonorrhoea. Methods N. gonorrhoeae isolates (n = 522) cultured in three regions of Belarus in 2009–2019 were examined. Determination of minimum inhibitory concentrations (MICs) of eight antimicrobials was performed using Etest. Resistance breakpoints from the European Committee on Antimicrobial Susceptibility Testing were applied where available. A Nitrocefin test identified β-lactamase production. Gonorrhoea treatment for 1652 patients was also analysed. Statistical significance was determined by the Z-test, Fisher’s exact test, or Mann-Whitney U test with p-values of < 0.05 indicating significance. Results In total, 27.8% of the N. gonorrhoeae isolates were resistant to tetracycline, 24.7% to ciprofloxacin, 7.0% to benzylpenicillin, 2.7% to cefixime, and 0.8% to azithromycin. No isolates were resistant to ceftriaxone, spectinomycin, or gentamicin. However, 14 (2.7%) isolates had a ceftriaxone MIC of 0.125 mg/L, exactly at the resistance breakpoint (MIC > 0.125 mg/L). Only one (0.2%) isolate, from 2013, produced β-lactamase. From 2009 to 2019, the levels of resistance to ciprofloxacin and tetracycline were relatively high and stable. Resistance to cefixime was not identified before 2013 but peaked at 22.2% in 2017. Only sporadic isolates with resistance to azithromycin were found in 2009 (n = 1), 2012 (n = 1), and 2018–2019 (n = 2). Overall, 862 (52.2%) patients received first-line treatment according to national guidelines (ceftriaxone 1 g). However, 154 (9.3%) patients received a nationally recommended alternative treatment (cefixime 400 mg or ofloxacin 400 mg), and 636 (38.5%) were given non-recommended treatment. Conclusions The gonococcal resistance to ciprofloxacin and tetracycline was high, however, the resistance to azithromycin was low and no resistance to ceftriaxone was identified. Ceftriaxone 1 g can continuously be recommended as empiric first-line gonorrhoea therapy in Belarus. Fluoroquinolones should not be prescribed for treatment if susceptibility has not been confirmed by testing. Timely updating and high compliance with national evidence-based gonorrhoea treatment guidelines based on quality-assured AMR data are imperative. The need for continued, improved and enhanced surveillance of gonococcal AMR in Belarus is evident.

scholarly journals Antimicrobial resistance in clinical bacterial isolates from horses in the UK

2021 ◽  
Author(s):  
C.M. Isgren ◽  
N.J. Williams ◽  
O.D. Fletcher ◽  
D. Timofte ◽  
J.R. Newton ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Bacterial Isolates ◽  
The Uk

scholarly journals INHIBITION OF PYOCYANIN PRODUCTION IN PSEUDOMONAS AERUGINOSA BY NATURAL ANTIMICROBIAL COMPOUNDS FROM HERBAL EXTRACTS

2017 ◽  
Vol 10 (6) ◽  
pp. 389
Author(s):  
Preeti Jain ◽  
Suman Kumari ◽  
Ashish Malik
Keyword(s):  
Methanol Extract ◽  
Growth Inhibitor ◽  
Dilution Method ◽  
Antimicrobial Compounds ◽  
Herbal Extracts ◽  
Antimicrobial Compound ◽  
Acetone Extracts ◽  
Microbroth Dilution ◽  
Growth Of Bacteria ◽  
Antibacterial Potential

Objective: P. aeruginosa produces a range of metabolites including pyocyanin that enhance its ability to resist antibiotics and becomes capable of surviving adverse conditions.Method: In this report, eight plants (extracted with five solvents) were screened for antibacterial activity against P. aeruginosa by microbroth dilution method. Afterward tested for inhibition of pyocyanin in presence and absence of plant extracts.Result: Among these D. muricata and S. quitoenes exhibited good antibacterial potential. Inhibition of pyocyanin is identified as a potential anti-virulence strategy. Therefore, acetone extract of six plants exhibited MIC ≤3.125mg/ml and methanol extract of three plants exhibited MIC ≤6.25mg/ml were used to check pyocyanin inhibition in P. aeruginosa. In acetone extracts, significant pyocyanin inhibition was found in I. pestigirdis and C. colocynthis. In methanol extracts, C. colocynthis and D. muricata showed considerable pyocyanin inhibition.Conclusion: Overall result indicates that the best antimicrobial compound (growth inhibitor) may not be best inhibitor of pyocyanin biosynthesis or vice-versa. Moreover, I. pestigirdis, C. colocynthis and D. muricata seems to contain compounds which inhibit the growth of bacteria as well as the biosynthesis of pyocyanin. 

scholarly journals Paradigm Shift in Antimicrobial Resistance Pattern of Bacterial Isolates during the COVID-19 Pandemic

Antibiotics ◽  
2021 ◽  
Vol 10 (8) ◽  
pp. 954
Author(s):  
Vikas Saini ◽  
Charu Jain ◽  
Narendra Pal Singh ◽  
Ahmad Alsulimani ◽  
Chhavi Gupta ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Antimicrobial Resistance ◽  
Tertiary Care ◽  
Public Health Problem ◽  
Resistance Pattern ◽  
Coagulase Negative Staphylococcus ◽  
Care Hospital ◽  
Bacterial Isolates ◽  
Hospital Infection Control ◽  
And Staphylococcus Aureus

Antimicrobial resistance (AMR) is an emerging public health problem in modern times and the current COVID-19 pandemic has further exaggerated this problem. Due to bacterial co-infection in COVID-19 cases, an irrational consumption of antibiotics has occurred during the pandemic. This study aimed to observe the COVID-19 patients hospitalized from 1 March 2019 to 31 December 2020 and to evaluate the AMR pattern of bacterial agents isolated. This was a single-center study comprising 494 bacterial isolates (blood and urine) that were obtained from patients with SARS-CoV-2 admitted to the ICU and investigated in the Department of Microbiology of a tertiary care hospital in Delhi, India. Out of the total bacterial isolates, 55.46% were gram negative and 44.53% were gram positive pathogens. Of the blood samples processed, the most common isolates were CoNS (Coagulase Negative Staphylococcus) and Staphylococcus aureus. Amongst the urinary isolates, most common pathogens were Escherichia coli and Staphylococcus aureus. A total of 60% MRSA was observed in urine and blood isolates. Up to 40% increase in AMR was observed amongst these isolates obtained during COVID-19 period compared to pre-COVID-19 times. The overuse of antibiotics gave abundant opportunity for the bacterial pathogens to gradually develop mechanisms and to acquire resistance. Since the dynamics of SARS-COV-2 are unpredictable, a compromise on hospital antibiotic policy may ultimately escalate the burden of drug resistant pathogens in hospitals. A shortage of trained staff during COVID-19 pandemic renders it impossible to maintain these records in places where the entire hospital staff is struggling to save lives. This study highlights the extensive rise in the use of antibiotics for respiratory illness due to COVID-19 compared to antibiotic use prior to COVID-19 in ICUs. The regular prescription audit followed by a constant surveillance of hospital infection control practices by the dedicated teams and training of clinicians can improve the quality of medications in the long run and help to fight the menace of AMR.

Sign in / Sign up

Export Citation Format

Share Document